Human Molecular Genetics Advance Access originally published online on April 13, 2005
Human Molecular Genetics 2005 14(11):1465-1474; doi:10.1093/hmg/ddi156
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas
1Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, ROC, 2Division of Cancer Research, National Health Research Institutes, Taipei, Taiwan, ROC, 3Departments of Internal Medicine and Oncology, National Taiwan University Hospital, Taipei, Taiwan, ROC and 4Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, ROC
* To whom correspondence should be addressed at: Division of Cancer Research, National Health Research Institutes, 7F, No. 161, Section 6, Min-Chuan E. Road, Taipei 114, Taiwan ROC. Tel: +886 226534401/25119; Fax: +886 227929654; Email: sechuang{at}nhri.org.tw
Received February 4, 2005; Accepted April 6, 2005
Apoptosis is a morphologically distinct form of cell death involved in many physiological and pathological processes. The regulation of Fas/Apo-1 involved in membrane-mediated apoptosis has also been known to play crucial roles in many systems. More and more naturally occurring antisense RNAs are now known to regulate, at least in part, a growing number of eukaryotic genes. In this report, we describe the findings of a novel RNA transcribed from the opposite strand of the intron 1 of the human Fas gene. Using orientation-specific RT–PCR and northern blot analysis, we show that this transcript is 1.5 kb in length and was expressed in several human tissues and cell lines. This transcript was cloned by 5'- and 3'-RACE (rapid amplification of cDNA ends) and the transcription start site was determined by primer extension. This novel gene was named Saf. To assess the functions of Saf, Jurkat cells transfected with human Saf or control vector was prepared. The stable Saf-transfectant was highly resistant to Fas-mediated but not to TNF-
-mediated apoptosis. Although the overall mRNA expression level of Fas was not affected, expression of some novel forms of Fas transcripts was increased in Saf-transfectant, especially the inhibitory soluble forms. These findings collectively suggest that Saf might protect T lymphocytes from Fas-mediated apoptosis by blocking the binding of FasL or its agonistic Fas antibody. Saf might regulate the expression of Fas alternative splice forms through pre-mRNA processing.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. E. Dinger, P. P. Amaral, T. R. Mercer, K. C. Pang, S. J. Bruce, B. B. Gardiner, M. E. Askarian-Amiri, K. Ru, G. Solda, C. Simons, et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation Genome Res., September 1, 2008; 18(9): 1433 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Mattick A new paradigm for developmental biology J. Exp. Biol., May 1, 2007; 210(9): 1526 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Pang, S. Stephen, M. E. Dinger, P. G. Engstrom, B. Lenhard, and J. S. Mattick RNAdb 2.0--an expanded database of mammalian non-coding RNAs Nucleic Acids Res., January 12, 2007; 35(suppl_1): D178 - D182. [Abstract] [Full Text] [PDF]
|
|